Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway

Fig. 2

CYT387 inhibits migration and invasion in glioblastoma cells. A Migration ability of U87-MG and LN229 was measured by wound healing test after treated with CYT387. B Invasion capacity of glioblastoma cells was measured by transwell assay after treated with CYT387. C MMP2 and MMP9 were detected by western blot after treatment with CYT387. All experiments were repeated at least three times. (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page